MedPath
FDA Product

propafenone hydrochloride

Product approved by U.S. Food and Drug Administration (US)

Basic Information

propafenone hydrochloride

68462-409

Regulatory Information

68462-409

ANDA205268

C73584

May 31, 2020

USA

These highlights do not include all the information needed to use PROPAFENONE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES safely and effectively. See full prescribing information for PROPAFENONE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES. PROPAFENONE HYDROCHLORIDE extended-release capsules, for oral useInitial U.S. Approval: 1989

HUMAN PRESCRIPTION DRUG LABEL

7

Company Information

130597813

Active Ingredients

PROPAFENONE HYDROCHLORIDE

Quantity: 325 mg in 1 1

Code: 33XCH0HOCD

Class Code: ACTIB

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

GELATIN, UNSPECIFIED

Code: 2G86QN327L

Class Code: IACT

LACTOSE MONOHYDRATE

Code: EWQ57Q8I5X

Class Code: IACT

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

SODIUM LAURYL SULFATE

Code: 368GB5141J

Class Code: IACT

POTASSIUM HYDROXIDE

Code: WZH3C48M4T

Class Code: IACT

SHELLAC

Code: 46N107B71O

Class Code: IACT

FERROSOFERRIC OXIDE

Code: XM0M87F357

Class Code: IACT

Active Moieties

PROPAFENONE

Code: 68IQX3T69U

© Copyright 2025. All Rights Reserved by MedPath